1. Home
  2. AAME vs SNTI Comparison

AAME vs SNTI Comparison

Compare AAME & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic American Corporation

AAME

Atlantic American Corporation

HOLD

Current Price

$1.71

Market Cap

34.7M

Sector

Finance

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.09

Market Cap

29.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAME
SNTI
Founded
1968
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.7M
29.8M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
AAME
SNTI
Price
$1.71
$1.09
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
14.1K
163.7K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
77.31
EPS
0.22
N/A
Revenue
$188,227,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.77
N/A
Revenue Growth
0.77
N/A
52 Week Low
$1.59
$0.77
52 Week High
$3.71
$2.88

Technical Indicators

Market Signals
Indicator
AAME
SNTI
Relative Strength Index (RSI) 38.94 57.03
Support Level $1.59 $0.88
Resistance Level $3.15 $1.19
Average True Range (ATR) 0.09 0.06
MACD 0.01 0.01
Stochastic Oscillator 28.00 64.66

Price Performance

Historical Comparison
AAME
SNTI

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: